New York State Common Retirement Fund’s LogicBio Therapeutics, Inc. Common Stock LOGC Stock Holding History

New York State Common Retirement Fund’s Portfolio LOGC Stock Details LOGC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-137	Closed	-$1K	–	3602
2021 Q2	$1K	Sell	137 -5,663	-98%	-$28.8K	﹤0.01%	3522
2021 Q1	$42K	Hold	5,800	–	–	﹤0.01%	3241
2020 Q4	$44K	Hold	5,800	–	–	﹤0.01%	3200
2020 Q3	$53K	Hold	5,800	–	–	﹤0.01%	3127
2020 Q2	$49K	Hold	5,800	–	–	﹤0.01%	3154
2020 Q1	$29K	Hold	5,800	–	–	﹤0.01%	3071
2019 Q4	$42K	Hold	5,800	–	–	﹤0.01%	3144
2019 Q3	$63K	Hold	5,800	–	–	﹤0.01%	3133
2019 Q2	$75K	Hold	5,800	–	–	﹤0.01%	3169
2019 Q1	$57K	Buy	+5,800	New	+$54K	﹤0.01%	3057

Other funds holding LOGC

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LPC

Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PVI

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

New York State Common Retirement Fund's LOGC Position: Q3 2021 in Review

New York State Common Retirement Fund sold out of LogicBio Therapeutics, Inc. Common Stock (LOGC) in Q3 2021, closing a stake of 137 shares — an estimated $1K sold.

New York State Common Retirement Fund first reported a position in LOGC in Q1 2019 and held it in 10 quarters. The position peaked at $75K in Q2 2019. 57 funds tracked by Wall St. Rank hold LOGC as of Q3 2021.

New York State Common Retirement Fund reported no remaining LogicBio Therapeutics, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
New York State Common Retirement Fund sold 137 LogicBio Therapeutics, Inc. Common Stock shares in Q3 2021, an estimated $1K.
New York State Common Retirement Fund first reported a position in LogicBio Therapeutics, Inc. Common Stock in Q1 2019 and held it in 10 quarters.
New York State Common Retirement Fund's LogicBio Therapeutics, Inc. Common Stock position peaked at $75K in Q2 2019.
57 funds tracked by Wall St. Rank held LogicBio Therapeutics, Inc. Common Stock as of Q3 2021.

Based on New York State Common Retirement Fund's 13F filing for Q3 2021, filed 2 Nov 2021.